Drug Establishment Licence doesn’t let TJP Labs sell pouches in Canada – yet

A Canadian company says Health Canada’s decision to grant it a Drug Establishment Licence (DEL) is another step towards its goal of eventually selling nicotine pouches in Canada though the department itself has confirmed to TobaccoIntelligence that it does not currently permit them to do so.

David Richmond-Peck, CEO of TJP Labs, said: “We carry a Health Canada drug licence which, we believe, would be a requirement for companies wanting to produce modern oral products in the future.”

Read full article
I'm already a subscriber
Author default picture


This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation